F. Bertrand et al., INSULIN ACTIVATES NUCLEAR FACTOR KAPPA-B IN MAMMALIAN-CELLS THROUGH ARAF-1-MEDIATED PATHWAY, The Journal of biological chemistry, 270(41), 1995, pp. 24435-24441
We examined the effect of insulin on nuclear factor kappa B (NF-kappa
B) activity in Chinese hamster ovary (CHO) cells overexpressing wild-t
ype (CHO-R cells) or -defective insulin receptors mutated at Tyr(1162)
and Tyr(1163) autophosphorylation sites (CHO-Y2 cells). In CHO-R cell
s, insulin caused a specific, time-, and concentration-dependent activ
ation of NF-kappa B. The insulin-induced DNA-binding complex was ident
ified as the p50/p65 heterodimer. Insulin activation of NF-kappa B: 1)
was related to insulin receptor number and tyrosine kinase activity s
ince it was markedly reduced in parental CHO cells which proved to res
pond to insulin growth factor-1 and phorbol 12-myristate 13-acetate (P
MA) activation, and was dramatically decreased in CHO-Y2 cells; 2) per
sisted in the presence of cycloheximide and was blocked by pyrrolidine
dithiocarbamate, aspirin and sodium salicylate, three compounds inter
fering with I kappa B degradation and/or NF-kappa B . I kappa B comple
x dissociation; 3) was independent of both PMA-sensitive and atypical
(zeta) protein kinases C; and 4) was dependent on Raf-1 kinase activit
y since insulin-stimulated NF-kappa B DNA binding activity was inhibit
ed by 8-bromo-cAMP, a Raf-1 kinase inhibitor. Moreover, insulin activa
tion of NF-kappa B-driven luciferase reporter gene expression was bloc
ked in CHO-R cells expressing a Raf-1 dominant negative mutant. This i
s the first evidence that insulin activates NF-kappa B in mammalian ce
lls through a post-translational mechanism requiring both insulin rece
ptor tyrosine kinase and Raf-1 kinase activities.